Monographie - Durvalumab

Zadnji put ažurirano :
03/05/2024

Durvalumab

Nekomercijalni

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Imfinzi

Francuska, Kanada, Njemačka, S A D, Švicarska, Velika Britanija

Bibliografija : Durvalumab

	Vrsta	Publikacija
4608	Laboratorija	Durvalumab (Imfinzi - Summery of Product Characteristics, updated August 2021) Astra Zeneca 2021
4767	Časopis	Almasi K, Thiesen J, Krämer I. Physicochemical stability of durvalumab (Imfinzi® ) concentrate for solution in original vials after first opening. Pharmaceutical Technology in Hospital Pharmacy 2023 ;8,1
4772	Časopis	Porlier A, Gagnon P-Y, Chénard V, Michael N-J, Simard C, Drolet B. Stability of Opened Durvalumab (IMFINZI) Vials. The Beginning of the End of Costly Product Wastage? J Pharm Sci 2023 ; 112, 9: 2412-2418.

Mentions Légales